Furosemide and Coarctation Surgery Lung Complications


in our study the investigators give furosemide during surgery for repair of aortic coarctation via lateral thoracotomy and evaluated lung complications in comparison to control group

Full Title of Study: “Furosemide: Would it Help to Improve the Lungs During Aortic Coarctation Surgery”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: Single (Participant)
  • Study Primary Completion Date: December 20, 2017


  • Drug: Furosemide
    • Administering furosemide

Arms, Groups and Cohorts

  • Experimental: F group
    • Furosemide group
  • No Intervention: C group
    • Control group

Clinical Trial Outcome Measures

Primary Measures

  • lung ultrasonography scale > 24
    • Time Frame: a 1 year study

Secondary Measures

  • Pao2/ Fio2 ratio
    • Time Frame: a 1 year study

Participating in This Clinical Trial

Inclusion Criteria

  • coarctation of aorta Exclusion Criteria:

  • heart failure, bleeding diathesis, associated cardiac congenital anomalies

Gender Eligibility: All

Minimum Age: 1 Month

Maximum Age: 18 Months

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Cairo University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Ahmed Kareem, Principal investigator – Cairo University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.